Voyager Therapeutics
VYGR
VYGR
131 hedge funds and large institutions have $196M invested in Voyager Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 37 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.14% less ownership
Funds ownership: 64.44% → 63.29% (-1.1%)
42% less call options, than puts
Call options by funds: $273K | Put options by funds: $474K
Holders
131
Holding in Top 10
–
Calls
$273K
Puts
$474K
Top Buyers
| 1 | +$4.2M | |
| 2 | +$1.58M | |
| 3 | +$1.56M | |
| 4 |
AC
Armistice Capital
New York
|
+$1.11M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$993K |
Top Sellers
| 1 | -$3.23M | |
| 2 | -$2.91M | |
| 3 | -$1.38M | |
| 4 |
Renaissance Technologies
New York
|
-$787K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$765K |